We live in a world where there is a large gap in the life expectancy between those who live in rich, developed nations and those who live in the poor, developing world. We know that innovation – scientific, technological, business, social and institutional – holds the promise of significantly narrowing this gap. At the McLaughlin-Rotman Centre for Global Health, we are focused on helping to bridge this gap by developing locally-relevant and empirically-grounded models to facilitate developing world innovation in global health.
Who We Are:
The McLaughlin-Rotman Centre for Global Health was established in 2004 at the University Health Network and the University of Toronto. We have close ties with foundations, such as the Bill & Melinda Gates Foundation, and with institutions in the developing world, who share the goal of enabling better, healthier lives for the world’s poor.
We have a global network of partners – scientists, entrepreneurs, policymakers and government officials, non-governmental organizations and funding agencies – that can help bring the models we develop to scale. Our comparative advantage lies in our strong focus on engaging and supporting “voices of the south” to generate domestic solutions for domestic problems, and the bright young minds of our graduate students and postdoctoral fellows from the developing and developed worlds who have embraced our mission, making it their mission. Our pool of talent includes some 60 or more researchers at the McLaughlin-Rotman Centre for Global Health.
What we do:
Global Grand Challenges Pillar
The McLaughlin-Rotman Centre for Global Health identifies opportunities to leverage funding from foundations, governments and other sources to undertake research leading to science-based breakthroughs to global health challenges. This pillar is focused on institutional innovation.
The Sandra A. Rotman Laboratories at the McLaughlin-Rotman Centre for Global Health is focused on biomedical research for new diagnostics and interventions for infectious diseases such as malaria, HIV, tuberculosis and sepsis, and translating new discoveries into clinical trials. This pillar is focused on technological innovation.
The McLaughlin-Rotman Centre for Global Health develops and brings forward social and institutional innovations designed to overcome ethical, social and cultural barriers to the acceptance of new medical technologies and to improve the diffusion and delivery of these technologies. This pillar is focused on social innovation.
The McLaughlin-Rotman Centre for Global Health develops financial and collaborative models to enhance the domestic and commercial production of health technologies in developing countries. This pillar is focused on business innovation.
For more information, please visit www.mrcglobal.org